Local anaesthesia is increasingly being used for vitreoretinal surgery, but the optimal technique for sedation remains unclear. Anaesthetist-administered midazolam, which is often used, was compared in this study to patient-controlled sedation with propofol in 43 patients undergoing 50 vitreoretinal procedures. A variety of patient, anaesthetist and surgical endpoints were measured. There were no significant outcome differences between the two agents except that midazolam produced more amnesia for the local anaesthetic eye block. However, several outcomes and the observations in patients who experienced both agents showed a trend in favour of propofol for intraoperative sedation. We conclude that both approaches are safe and that patient-controlled sedation with propofol is at least as satisfactory as anaesthetist-administered midazolam.
Local anaesthesia is now frequently used for vitreoretinal surgery, although there is controversy about its limitations in repeat surgery 1 , prolonged surgery 2 , and scleral buckling or combined scleral buckling and vitrectomy 3 .
The advantages of local anaesthesia which are especially relevant in the elderly include the avoidance of the risks of general anaesthesia, less frequent intraoperative bradycardia and hypertension, less requirement for postoperative opioid, less postoperative vomiting 4 , quicker recovery and early cooperation with positioning when intraocular gas has been used.
Sedation is necessary for many, if not all, patients undergoing vitreoretinal surgery under local anaesthesia. It helps to allay anxiety and perhaps undesirable cardiovascular reaction to stress 5 . It enables patients to tolerate the prolonged immobility needed for this type of surgery. Many patients appreciate the partial amnesia which sedation can provide. Sedation will also assist in covering short periods of time when the local anaesthesia needs supplementing. This has been reported to be required in a varying proportion of patients, between 19 and 80%, depending on several factors, including the exact type of surgery [1] [2] [3] 6, 7 .
Sedation presents special challenges in these patients: they must remain fully cooperative; sedation must be safe, since many of these patients are elderly with comorbidities such as cardiac or respiratory disease, yet individual pharmacokinetic and pharmacodynamic differences make safe sedation more difficult to achieve; and monitoring in the usual way using a sedation scale is more difficult because there is no access to the patient's head, nor is free verbal communication usually possible.
The standard method for sedation is administration of midazolam by the anaesthetist. Midazolam is a very satisfactory and safe drug when administered intravenously in small boluses until the desired level of sedation is reached. Even light sedation is accompanied by anxiolysis 8 and amnesia 9 . However the relatively slow rate of onset and offset of its action may at times be a disadvantage.
Patient-controlled sedation (PCS) may be an alternative to anaesthetist-administered midazolam. By allowing the patient to titrate sedation to his/her own requirements, patient-controlled sedation overcomes pharmacokinetic and pharmacodynamic differences between patients and variability in discomfort or surgical stimuli during the procedure.
Propofol has been demonstrated to be particularly useful for this technique because of its short onset time and reliable effect on mood 10 . It produces partial amnesia even at conscious sedation levels 11 . Patientcontrolled sedation with propofol has been used in oral surgery, general and orthopaedic surgery, gynaecology, interventional neuroradiologic procedures and for cataract surgery [12] [13] [14] [15] [16] [17] [18] .
Although studies have been carried out to assess satisfactory methods of sedation before retrobulbar and peribulbar blocks [19] [20] [21] , and during anterior segment surgery 18, 22 to our knowledge no studies with the sole aim of assessing methods of sedation during vitreoretinal surgery under local anaesthesia have been carried out.
We have therefore undertaken this study to compare standard sedation with midazolam to patientcontrolled sedation with propofol.
METHODS
Approval for the study was given by the Royal Adelaide Hospital Ethics Committee. Patients were restricted to ASA physical status classes 1, 2 and 3, were required to have adequate communication skills and were excluded if liver or renal failure (creatinine clearance <25 ml/min) was present.
Patients were allocated using randomization balanced for patients' age greater or less than 70 years. Midazolam patients were given anaesthetistadministered midazolam. Propofol patients used patient-controlled sedation (PCS) with propofol. Patients having repeat surgery during the study were allocated to receive the alternative method of sedation, thus forming a small crossover study.
Midazolam patients received small boluses of midazolam, 0.5 mg in most patients and 0.25 mg in the very elderly, starting at least five minutes before the local anaesthetic block to allow titration to an endpoint of relaxation and slight drowsiness. During surgery one quarter to one half of the pre-block dose, depending on the initial response and age of the patient, was administered at half-hour intervals.
Propofol patients used a programmable syringe pump activated by a patient-controlled device. For the majority of patients this was a B Braun Perfusor syringe pump (GE08719446/GE08713898, B Braun Medical, Castle Hill, N.S.W.) which was chosen because of its ability to deliver rapidly the small boluses of propofol used in this study. Each activation of the device was accompanied by a tone which indicated that either a bolus of propofol would follow or the demand had occurred during the lockout period. The display on the pump allowed the anaesthetist to follow the current PCS status and the course of the propofol administration. The bolus of propofol selected was 18 mg for patients aged 70 or less and 15 mg for those older; the former was delivered over 6.5 seconds, the latter over 5.4. If a patient showed too marked a response, the bolus was reduced to 15 or 10 mg respectively. A lockout time of one minute was selected. These values have previously been shown to be satisfactory 12 .
Propofol patients were instructed to use one to three boluses of propofol to achieve mild sedation, starting approximately five minutes before the block. The last five propofol patients also used an additional one to two boluses between the first and second peribulbar injection. During the surgical procedure, the patient administered propofol to the level of sedation he/she required.
The peribulbar block was administered in a standard fashion by the anaesthetist (HM), surgeon (HN), or eye registrar. The anaesthetic solution used was a mixture of equal volumes of 2% lignocaine and 0.5% bupivacaine with 30 units/ml of hyaluronidase. Medial and inferotemporal injections were made in all patients and if indicated, a third injection was given just below the orbital roof at the junction of its inner third and outer two thirds. Manual pressure or a Honan balloon was placed on the eye following the block. The mean volume of local anaesthetic used for the block was 9.8 ml.
If the patient complained of pain in the eye during surgery, the surgeon supplemented the local anaesthetic using 0.5% bupivacaine via a sub-Tenon's capsule approach to the retrobulbar space. If the patient was uncomfortable due to his/her position on the table, the anaesthetist administered fentanyl in boluses of 25 µg to a maximum dose of 100 µg. Each patient received oxygen via nasal cannula or a mixture of oxygen/air via a facemask and was monitored throughout the procedure by continuous pulse oximetry and ECG, and NIBP, pulse and respiratory rate at 10 minute intervals.
Patient cooperation was graded by the surgeon using a score from 1 (no movement) to 4 (movement requiring a general anaesthetic), and by the anaesthetist using a score of 1 (full cooperation) to 5 (no cooperation, procedure abandoned). On the morning following surgery, in conjunction with the eye registrar who was unaware of the sedation technique used, the patient filled in a questionnaire assessing memory and pain associated with the local anaesthetic block; memory and eye pain during the surgical procedure; degree of relaxation and comfort during the procedure, and whether the patient would undergo the operation the same way again. The patient was also asked to make free comments about the experience. Memory of the block required a yes/no answer; pain associated with the block and eye pain during surgery, and memory of the surgical procedure were assessed using visual analog scales marked 1 to indicate no pain or memory and 10 to indicate very severe pain or complete memory of the procedure. Likewise a score of 1 indicated complete comfort and relaxation during the surgery and 10 extreme anxiety and/or discomfort during surgery.
Patients who underwent repeat surgery were, either on the first postoperative day or subsequently by mail, asked which method was preferred and the reason for any preference.
Statistics
Groups were compared by the two-tailed Wilcoxon rank-sum or the two-tailed Fisher's exact test.
RESULTS
Forty-three patients were enrolled into the study. Seven had repeat procedures during the study period so that a total of 50 operative episodes were evaluated. In addition, a preference was obtained from one patient in the propofol group who had undergone vitreoretinal surgery three months earlier and had been sedated with midazolam in an identical manner to the study patients. The surgical procedures performed were vitrectomy in 14 patients (midazolam 6, propofol 8), explant in 22 (midazolam 12, propofol 10), vitrectomy and explant in 12 (midazolam 4, propofol 8), and removal of silicone oil in 2 (midazolam 0, propofol 2).
Patient and drug details are summarized in Table 1 . Six propofol patients received a mean dose of fentanyl of 50 µg and five midazolam patients received a mean dose of 40 µg.
The mean percentage of successful demands made by patients using PCS was 80% (range 23 to 100%).
Outcome measures related to the patient, surgeon and anaesthetist are shown in Table 2 . There was no significant difference in any outcome variable except a lower proportion of patients in the midazolam group who had memory of the eye block (P=0.03, Fishers exact test, two-tailed). Propofol patients tended to score the pain of the block higher than midazolam patients. However, in the last five propofol patients, who were instructed to administer one to two more boluses of propofol prior to the second peribulbar injection, pain scores ranged from 1 to 3, i.e., similar to midazolam patients, whereas in the first 23 propofol patients, pain scores ranged from 1 to 9 and were greater than three in five patients. For the intraoperative period, there were no trends tending to favour one technique of sedation over the other, except perhaps in patients having repeat procedures.
There was some imbalance in the number of repeat procedures performed in the two groups. Eight (36%) of 22 procedures in midazolam patients compared to 14 (50%) of 28 procedures in propofol patients were performed on an eye which had previously been operated on. Overall, repeat surgery was associated with more pain of block (median of repeat 2 vs median of initial 1, P=0.07), more intraoperative eye pain (repeat 2 vs initial 1, P=0.17), and more intraoperative discomfort (repeat 3 vs 2, P=0.09). When only patients having repeat surgery were con- It was possible to compare patient preferences for the two drugs in seven patients who had two operations on the one eye and one patient who had one operation on each eye (Table 3 ). For the group of seven patients one would expect the patients to prefer the drug used for the initial operation. Midazolam was the drug used for the first operation in six of the seven patients, but despite this, the trend of patient preferences favoured propofol.
Adverse events
Of the patients receiving midazolam, one was oversedated prior to the block, one developed mild hypertension and tachycardia intraoperatively, thought to be associated with restlessness caused by midazolam, and a third who had cardiac disease developed a heart rate of 120 shortly after surgery began but it settled without treatment.
Of those patients receiving propofol, one was oversedated prior to the block. Two patients became disinhibited, leading to stopping the sedation in one patient and asking the other patient to stop talking. Another patient using PCS with propofol for each of two separate operations developed moderate hypertension and tachycardia on each occasion because the local anaesthetic could not be adequately supplemented.
There were no serious complications in any of the patients and the surgical procedure was completed satisfactorily in all patients.
DISCUSSION.
Overall, the results of this study did not reveal any major differences between the two methods of sedation. With regard to sedation during the block, there was significantly less memory of the block in midazolam patients, which accords with the clinical impression that amnesia with midazolam is greater than with propofol. The median score for pain during the block was slightly greater for propofol than for midazolam, 2 compared with 1, although this did not reach statistical significance. The pain scores of the last five patients receiving propofol, who were instructed to administer additional boluses between the first and second peribulbar injections ranged from 1 to 3, similar to that of the midazolam patients. Thus we conclude that for the eye block, at approximately the same levels of light sedation and cooperation which were achieved for most patients during the block, propofol may provide less amnesia but similar satisfactory pain scores to midazolam. Other studies 19, 20 demonstrate that gaining deeper levels of sedation and amnesia for the eye block increases the risk of movement during injection, respiratory complications and verbal reactions.
The results of assessments for the intraoperative period did not show any significant differences between propofol and midazolam. There were few adverse events and their frequency between the two groups was similar. There were, however, a few trends in favour of propofol. Repeat surgery has previously been reported to be associated with greater pain and discomfort 1 , and the same association was seen in this study. Despite the fact that a greater proportion of propofol patients were having repeat surgery, there was, overall, no significant difference between the two drugs in the subjectively assessed measures of pain or discomfort. When only patients having repeat surgery were considered, there was a trend for less discomfort with propofol than with midazolam. The need for local supplementation provides a more objective measurement than these subjective measures, and a lower proportion of propofol than midazolam patients required local supplementation. This finding may reflect the ability of patients using PCS with propofol to control and tolerate minor degrees of pain without requiring more local anaesthetic. For the eight patients who received both agents and were asked to state their preference, four favoured propofol, two rated the two drugs as equal, and two favoured midazolam. The preference for propofol was observed despite the fact that the drug used for a repeat operation was propofol in six and midazolam in only one.
Infrequently, for technical reasons, local anaesthetic supplementation cannot be carried out or is ineffective 23 . In our study this occurred on two occasions in the same patient. The two procedures were almost certainly only carried out successfully and safely without employing general anaesthesia because on each occasion the patient was using PCS with propofol. The free comments by patients, particularly those able to compare both methods, provided some reasons for patient preferences. The four patients who preferred propofol gave as their reasons the ability to control sedation and any discomfort or pain without disturbing the surgeon. One of these patients, under insufficient sedation with midazolam, had suffered postoperative nightmares because she could recall surgical instruments approaching her eye, whereas she "could relax and didn't remember much using propofol". The two patients who preferred midazolam were happier for the anaesthetist to control sedation; one of these patients was concerned that he might oversedate himself. There may be a tendency for younger patients to prefer patientcontrolled sedation and older patients, anaesthetistadministered sedation.
Four midazolam and two propofol patients would not repeat the operation the same way again. Two of the four midazolam patients would undergo the procedure under local anaesthesia again, provided they could use PCS with propofol, while another patient given midazolam had felt "closed in". Of the two propofol patients who would not repeat the experience, one did not use the PCS because of a language barrier and then commented she had felt scared, while the second patient, as discussed previously, had inadequate analgesia.
If PCS with propofol is an available option, both it and anaesthetist-controlled sedation should be carefully explained to the patient so that he/she can make an informed choice. As with any sedative technique, patients using PCS must be carefully monitored and the anaesthetist should be prepared to reduce the size of the bolus dose or discontinue this method if there are any problems.
In summary, midazolam produces more amnesia for the eye block, but may be inferior to propofol for intraoperative sedation. Patients, especially younger ones, tend to prefer propofol, which may be more satisfactory for repeat surgery on the same eye, and it safely covers the unpredictable, although not common, problem of a local anaesthetic which cannot be adequately supplemented. Patients using PCS with propofol can safely titrate sedation to their needs and to periods of incomplete analgesia.
An important outcome of this study is the demonstration of satisfaction of the surgeon, the anaesthetist and the patients with vitreoretinal surgery carried out under local anaesthesia, whether anaesthetist-administered midazolam or patient-controlled sedation with propofol is used. The successful use of local anaesthesia for vitreoretinal surgery 1, 6, 7, 23, 24 has encouraged some centres to perform the procedure on a day patient basis. The technical success rate of such management equals that of patients managed traditionally with general anaesthesia and hospitalization 25 , and the majority of patients are satisfied 26 . Day patient surgery also produces significant cost savings. Although only four out of the 50 patients in this study were managed as day patients, we hope soon to perform vitreoretinal surgery as a day procedure in the majority of our patients.
